[Form 4] Kindly MD, Inc. Insider Trading Activity
Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer’s common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.
Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell’emittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione è firmata in data 22/08/2025. Il modulo indica esclusivamente un’acquisizione non derivata e non fornisce ulteriori dettagli sulle modalità o sulla controprestazione dell’operazione.
Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), informó en el Form 4 que el 14/08/2025 adquirió 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentación está firmada el 22/08/2025. El formulario solo muestra una adquisición no derivada y no aporta detalles adicionales sobre la mecánica o la contraprestación de la transacción.
Tyler Matthew Evans는 Kindly MD, Inc.(NAKA)의 Chief Investment Officer 겸 이사로 확인되며, Form 4에 따르면 2025-08-14에 발행회사의 보통주 2,232,114주를 보고된 가격 $0로 취득하여 총 실질 보유주식 수를 2,410,685주로 늘렸습니다. 해당 서류는 2025-08-22에 서명되었습니다. 양식에는 비파생(non-derivative) 취득만 기재되어 있으며 거래의 방식이나 대가에 관한 추가 설명은 없습니다.
Tyler Matthew Evans, identifié comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a déclaré sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l’émetteur à un prix déclaré de 0 $, portant sa détention bénéficiaire totale à 2 410 685 actions. Le document est signé le 22/08/2025. Le formulaire n’indique qu’une acquisition non dérivée et ne fournit aucun détail supplémentaire sur les modalités ou la contrepartie de la transaction.
Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enthält keine weiteren erläuternden Angaben zu den Modalitäten oder der Gegenleistung der Transaktion.
- Insider acquisition disclosed: Reporting person acquired 2,232,114 common shares, increasing transparency about insider ownership.
- None.
Insights
TL;DR: Insider acquired a large block of company stock; filing reports quantity but not economic consideration.
The Form 4 discloses a non-derivative acquisition of 2,232,114 common shares by Tyler Evans, bringing his total to 2,410,685 shares. The transaction date is 08/14/2025 and the report shows a price of $0, with no derivative activity disclosed. From a securities-transaction perspective, the report documents a material shareholding change by a senior officer and director. However, the filing lacks contextual details on how the acquisition was executed or funded, which limits assessment of economic impact.
TL;DR: Officer/director reported sizable share acquisition; the $0 price notation needs clarification in follow-up filings.
As Chief Investment Officer and director, Evans’ increased stake to 2,410,685 shares is notable for ownership disclosure and governance transparency. The Form 4 contains the required signature and dates but does not explain the $0 price or indicate a Rule 10b5-1 plan; absence of that detail means investors must rely solely on the disclosed numbers. This filing satisfies the basic Section 16 reporting obligation but invites questions about the transaction’s nature that are not answered in this record.
Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell’emittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione è firmata in data 22/08/2025. Il modulo indica esclusivamente un’acquisizione non derivata e non fornisce ulteriori dettagli sulle modalità o sulla controprestazione dell’operazione.
Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), informó en el Form 4 que el 14/08/2025 adquirió 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentación está firmada el 22/08/2025. El formulario solo muestra una adquisición no derivada y no aporta detalles adicionales sobre la mecánica o la contraprestación de la transacción.
Tyler Matthew Evans는 Kindly MD, Inc.(NAKA)의 Chief Investment Officer 겸 이사로 확인되며, Form 4에 따르면 2025-08-14에 발행회사의 보통주 2,232,114주를 보고된 가격 $0로 취득하여 총 실질 보유주식 수를 2,410,685주로 늘렸습니다. 해당 서류는 2025-08-22에 서명되었습니다. 양식에는 비파생(non-derivative) 취득만 기재되어 있으며 거래의 방식이나 대가에 관한 추가 설명은 없습니다.
Tyler Matthew Evans, identifié comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a déclaré sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l’émetteur à un prix déclaré de 0 $, portant sa détention bénéficiaire totale à 2 410 685 actions. Le document est signé le 22/08/2025. Le formulaire n’indique qu’une acquisition non dérivée et ne fournit aucun détail supplémentaire sur les modalités ou la contrepartie de la transaction.
Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enthält keine weiteren erläuternden Angaben zu den Modalitäten oder der Gegenleistung der Transaktion.